Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 12,818 shares at $224.41 ($2.9M) on 2022-12-01, disclosed to the SEC on 2022-12-05.
Open-market sale of $2.9M CRL by EVP, Corporate Strategy & Develop. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $223.06 | 1,138 | $254K | 8.8% |
| 2 | $223.06 | 1,138 | $254K | 8.8% |
| 3 | $224.41 | 4,165 | $935K | 32.5% |
| 4 | $224.41 | 4,165 | $935K | 32.5% |
| 5 | $224.85 | 1,106 | $249K | 8.7% |
| 6 | $224.85 | 1,106 |
| $249K |
| 8.7% |
| Total | $224.25 avg | 12,818 | $2.9M | 100% |
| Filing → |
| CRL | SELL | 2025-08-20 | $126K | — | Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |